Live from the NIH registry
Studies recruiting near Aurora right now
Top 25 of 616 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Loyola University Medical Center (Adults and Pediatrics) — Maywood, Illinois (24.4 mi)
· Sponsor: Pierre Fabre Medicament
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Edward-Elmhurst Cancer Center /ID# 238552 — Elmhurst, Illinois (20.3 mi)
· Sponsor: AbbVie
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Nephrology Associates of Northern Illinois and Indiana (NANI Research) — Oak Brook, Illinois (19.2 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Dr. Sudarshan K. Sharma, Ltd. — Hinsdale, Illinois (18.4 mi)
· Sponsor: Kartos Therapeutics, Inc.
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Hinsdale, Illinois (18.4 mi)
· Sponsor: AstraZeneca
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (27.5 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Endeavor Health Cancer Institute at Swedish Hospital — Naperville, Illinois (7.5 mi)
· Sponsor: Pfizer
Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement
Healthy Adult
N/A
Interventional 34 participants sought
Biofortis Clinical Research — Addison, Illinois (19.4 mi)
· Sponsor: Shaklee Corporation
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (27.5 mi)
· Sponsor: Immuneering Corporation
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Midwest Cardiovascular Institute — Naperville, Illinois (7.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
University Retina and Macula Associates, PC — Lemont, Illinois (16.1 mi)
· Sponsor: Genentech, Inc.
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Alzheimers Disease, Dementia
Phase 2, Phase 3
Interventional 280 participants sought
Advocate Lutheran General Hospital — Park Ridge, Illinois (28.8 mi)
· Sponsor: Washington University School of Medicine
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Northwestern Medicine Cancer Center Warrenville — Warrenville, Illinois (7.1 mi)
· Sponsor: NRG Oncology
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10025, Naperville, IL — Naperville, Illinois (7.5 mi)
· Sponsor: Colorado Prevention Center
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Solid Tumours
Phase 2
Interventional 588 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (27.5 mi)
· Sponsor: Boehringer Ingelheim
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
Perinatal Decision Making
N/A
Interventional 2,200 participants sought
Rush Copley Medical Center — Aurora, Illinois (1.6 mi)
· Sponsor: Endeavor Health
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Clostridioides Difficile Infection
Phase 2
Interventional 230 participants sought
Research Site — Burr Ridge, Illinois (19.2 mi)
· Sponsor: AstraZeneca
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Southwest Gastroenterology — Oak Lawn, Illinois (27.7 mi)
· Sponsor: Ardelyx
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Northwestern Medicine Central DuPage Hospital — Winfield, Illinois (9.5 mi)
· Sponsor: Children's Oncology Group
SELUTION4BTK Trial
Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
N/A
Interventional 376 participants sought
Advocate Lutheran General Hospital — Park Ridge, Illinois (28.8 mi)
· Sponsor: M.A. Med Alliance S.A.
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma
Phase 1, Phase 2
Interventional 97 participants sought
University of Chicago Medicine-Orland Park — Orland Park, Illinois (24.3 mi)
· Sponsor: National Cancer Institute (NCI)
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
Prostate Cancer
Phase 2
Interventional 60 participants sought
Edward Hines Jr. VA Hospital, Hines, IL — Hines, Illinois (24.0 mi)
· Sponsor: VA Office of Research and Development
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1148 — Elgin, Illinois (18.9 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Hinsdale, Illinois (18.4 mi)
· Sponsor: AstraZeneca
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Rush-Copley Medical Center — Aurora, Illinois (1.6 mi)
· Sponsor: NRG Oncology